Long-term galantamine treatment improved survival; lowered blood pressure; reduced renal injury markers, including urinary albumin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin; and decreased renal fibrosis in female mice with SLE. The gene discussed is ALB; the disease is renal fibrosis.